PDCO
35
-5
PHM
63
4
GT
67
3
UNH
67
3
ISRG
77
2
DD
60
-7
FITB
65
3
KR
52
2
NRG
75
-2
CL
50
3
MAC
62
4
AKAM
40
-22
STI
17
10
LLY
50
11
SCHW
56
3
MPC
44
3
ABT
62
5
KMB
30
2
GE
71
7
NI
68
5
PDCO
35
-5
PHM
63
4
GT
67
3
UNH
67
3
ISRG
77
2
DD
60
-7
FITB
65
3
KR
52
2
NRG
75
-2
CL
50
3
MAC
62
4
AKAM
40
-22
STI
17
10
LLY
50
11
SCHW
56
3
MPC
44
3
ABT
62
5
KMB
30
2
GE
71
7
NI
68
5
Financhill
Back

Tourmaline Bio Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
33

TRML
Tourmaline Bio

Last Price:
28.74
Seasonality Move:
22.61%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Tourmaline Bio Price Quote

$28.74
-0.02 (3.9%)
(Updated: November 9, 2024 at 5:49 AM ET)

Tourmaline Bio Key Stats

Sell
33
Tourmaline Bio (TRML) is a Sell
Day range:
$26.39 - $29.55
52-week range:
$12.12 - $48.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.18%
Volume:
237.8K
Avg. volume:
228.8K
1-year change:
85.67%
Market cap:
$737.4M
Revenue:
$0
EPS:
$-1.47

How Much Does Tourmaline Bio Make?

Data Unavailable

Is Tourmaline Bio Growing As A Company?

Data Unavailable

Tourmaline Bio Stock Price Performance

  • Did Tourmaline Bio Stock Go Up Last Month?
    Tourmaline Bio share price went up by 0.95% last month
  • Did TRML's Share Price Rise Over The Last Year?
    TRML share price rose by 85.67% over the past 1 year

What Is Tourmaline Bio 52-Week High & Low?

Tourmaline Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tourmaline Bio?

  • How Much Debt Does Tourmaline Bio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Tourmaline Bio Have?
    Cash and short term investments quarterly total is $289.5M
  • What Is Tourmaline Bio’s Book Value Per Share?
    Book value per share is 13.19

Is Tourmaline Bio Cash Flow Positive?

  • What Is TRML Cash Flow From Operations?
    Cash flow from operations (TTM) is -$47.7M
  • What Is Tourmaline Bio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $225.9M
  • What Is Tourmaline Bio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$195.1M

Tourmaline Bio Return On Invested Capital

Data Unavailable

Tourmaline Bio Earnings Date & Stock Price

Tourmaline Bio Competitors

  • Who Are Tourmaline Bio's Competitors?
    Below is a list of companies who compete with Tourmaline Bio or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)

Tourmaline Bio Dividend Yield

Tourmaline Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.45%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 58.33
Upside from Last Price: 102.83%

Major Shareholders

  • How many TRML shares are owned by institutional investors?
    32.7M TRML shares are owned by institutional investors
  • How many TRML shares are owned by insiders?
    1.6M TRML shares are owned by insiders